Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by BlueJays9293on Feb 24, 2024 10:43pm
130 Views
Post# 35897603

RE:RE:RE:RE:RE:RE:RE:Peeking is very real.

RE:RE:RE:RE:RE:RE:RE:Peeking is very real.
Slow down cowboy, I just finished making a more detailed breakdown of Spectral's slide #7, for myself and also as a cheat sheet for Spectral's negotiation team, just kidding I'm sure they already know this lol.  If you want to know it's potential impact to Vantives market cap, just slap a zero on the end of each profit number.  
 
Now if you or anyone else wants to go do your own spreadsheet and incorporate all the true things you are talking about, have at it, this is just a starting framework.  
 
1% penetration = 6.2mm profit.
2.5% = 15.5mm
5% = 31mm
7.5% = 46mm 
10% = 62mm
12.5% = 68mm
15% = 93mm
17.5% = 109mm
20% = 124mm
22.5% = 140mm
25% = 155mm
27.5% = 171mm
30% = 185mm
32.5% = 202mm
35% = 217mm
37.5% = 233mm
40% = 247mm
42.5% = 264mm
45% = 279mm
47.5 = 295mm
50% = 309mm

 
 
 

<< Previous
Bullboard Posts
Next >>